Market News

Inside Trading: Shai Gozani Acquired 5,000 Shares of NeuroMetrix, Inc. (NURO); Spectrasite (SSI) Has 0.7 Sentiment

Stage Stores, Inc. operates specialty department stores primarily in small and mid-sized towns and communities in the United States. The company has market cap of $47.80 million. The Company’s merchandise portfolio comprises moderately priced brand name and private label apparel, accessories, cosmetics, footwear, and home goods. It currently has negative earnings. The firm also offers merchandise direct-to-consumer through its e-commerce Website and send program.

The President & CEO of Neurometrix Inc, Shai Gozani, has just acquired – 5,000 shares of the firm she’s managing – coming to an aggregate transaction of $6,375 USD (this based on share price of $1.3). She also purchased 10,000 shares with a market value $15,751 USD in the last 30 days. Shai Gozani now holds 71,196 shares which are equivalent to roughly 3.04% of the Massachusetts-based company’s total market cap. The investment was unveiled in a SEC filing on 09/02/2018.

Paradigm Capital Management Inc Ny holds 0.44% of its portfolio in Stage Stores, Inc. for 2.74 million shares. Capstone Financial Advisors Inc. owns 22,035 shares or 0.02% of their US portfolio. Moreover, Cubist Systematic Strategies Llc has 0.01% invested in the company for 77,290 shares. The United Kingdom-based Gsa Capital Partners Llp has invested 0.01% in the stock. Quinn Opportunity Partners Llc, a New York-based fund reported 35,000 shares.

The stock decreased 1.14% or $0.02 during the last trading session, reaching $1.73. About 176,289 shares traded. Stage Stores, Inc. (SSI) has declined 49.89% since February 10, 2017 and is downtrending. It has underperformed by 66.59% the S&P500.

Ratings analysis reveals 0 of Stage Stores’s analysts are positive. Out of 2 Wall Street analysts rating Stage Stores, 0 give it “Buy”, 1 “Sell” rating, while 1 recommend “Hold”. SSI was included in 2 notes of analysts from August 19, 2016. Northcoast downgraded the shares of SSI in report on Friday, November 18 to “Sell” rating. The rating was maintained by Telsey Advisory with “Market Perform” on Friday, August 19.

The stock decreased 7.19% or $0.1 during the last trading session, reaching $1.29. About 492,347 shares traded. NeuroMetrix, Inc. (NASDAQ:NURO) has declined 68.03% since February 10, 2017 and is downtrending. It has underperformed by 84.73% the S&P500.

Leave a Reply

Your email address will not be published. Required fields are marked *